LEHI, Utah., Sept. 12, 2024. Biolexis Therapeutics, a biopharmaceutical company pioneering next-generation weight loss treatments, today announced the...

COMM collaborates with NOK to develop a cutting-edge AI-driven solution for improved connectivity across different verticals.

COMM collaborates with NOK to develop a cutting-edge AI-driven solution for improved connectivity across different verticals.

QGEN collaborates with Eli Lilly to develop a QIAstat-Dx IVD panel for APOE genotyping.

QGEN collaborates with Eli Lilly to develop a QIAstat-Dx IVD panel for APOE genotyping.

MASI Collaborates with Qualcomm to develop a reference platform for Wear OS smartwatches, combining biosensing tech and Snapdragon chips to enhance...

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the nomination...

Italy is looking to create a new company to build small nuclear reactors, and officials are in preliminary talks with Ansaldo Nucleare SpA, Enel SpA,...

Alterity Therapeutics has its roots in developing drugs for neurodegeneration with its latest focus on Parkinson’s disease and related disorders,...

HONG KONG, Sept. 17, 2024. Ascletis Pharma Inc. ("Ascletis") announces today completion of initial dosing in its two recently initiated U.S. Phase I...